| Prognostic survival associated with left-sided vs right-sided colon cancer: a systematic review and meta-analysis F Petrelli, G Tomasello, K Borgonovo, M Ghidini, L Turati, P Dallera, ... JAMA oncology 3 (2), 211-219, 2017 | 758 | 2017 |
| Trifluridine/tipiracil versus placebo in patients with heavily pretreated metastatic gastric cancer (TAGS): a randomised, double-blind, placebo-controlled, phase 3 trial K Shitara, T Doi, M Dvorkin, W Mansoor, HT Arkenau, A Prokharau, ... The Lancet Oncology 19 (11), 1437-1448, 2018 | 426 | 2018 |
| Total neoadjuvant therapy in rectal cancer: a systematic review and meta-analysis of treatment outcomes F Petrelli, F Trevisan, M Cabiddu, G Sgroi, L Bruschieri, E Rausa, ... Annals of surgery 271 (3), 440-448, 2020 | 324 | 2020 |
| Effect of pathologic tumor response and nodal status on survival in the medical research council adjuvant gastric infusional chemotherapy trial EC Smyth, M Fassan, D Cunningham, WH Allum, AFC Okines, A Lampis, ... Journal of Clinical Oncology 34 (23), 2721, 2016 | 265 | 2016 |
| Association of obesity with survival outcomes in patients with cancer: a systematic review and meta-analysis F Petrelli, A Cortellini, A Indini, G Tomasello, M Ghidini, O Nigro, M Salati, ... JAMA Network Open 4 (3), e213520-e213520, 2021 | 249 | 2021 |
| Association of steroids use with survival in patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis F Petrelli, D Signorelli, M Ghidini, A Ghidini, EG Pizzutilo, L Ruggieri, ... Cancers 12 (3), 546, 2020 | 216 | 2020 |
| MicroRNAs (miRNAs) and long non-coding RNAs (lncRNAs) as new tools for cancer therapy: first steps from bench to bedside M Ratti, A Lampis, M Ghidini, M Salati, MB Mirchev, N Valeri, JC Hahne Targeted oncology 15, 261-278, 2020 | 208 | 2020 |
| FOLFOXIRI plus bevacizumab as conversion therapy for patients with initially unresectable metastatic colorectal cancer: a systematic review and pooled analysis G Tomasello, F Petrelli, M Ghidini, A Russo, R Passalacqua, S Barni JAMA oncology 3 (7), e170278-e170278, 2017 | 188 | 2017 |
| Tumor regression grade and survival after neoadjuvant treatment in gastro-esophageal cancer: a meta-analysis of 17 published studies G Tomasello, F Petrelli, M Ghidini, E Pezzica, R Passalacqua, ... European Journal of Surgical Oncology 43 (9), 1607-1616, 2017 | 125 | 2017 |
| The efficacy of lapatinib and capecitabine in HER-2 positive breast cancer with brain metastases: a systematic review and pooled analysis F Petrelli, M Ghidini, V Lonati, G Tomasello, K Borgonovo, M Ghilardi, ... European Journal of Cancer 84, 141-148, 2017 | 121 | 2017 |
| Comparative effectiveness of gemcitabine plus nab-paclitaxel and FOLFIRINOX in the first-line setting of metastatic pancreatic cancer: a systematic review and meta-analysis S Pusceddu, M Ghidini, M Torchio, F Corti, G Tomasello, M Niger, N Prinzi, ... Cancers 11 (4), 484, 2019 | 99 | 2019 |
| The sexist behaviour of immune checkpoint inhibitors in cancer therapy? A Botticelli, CE Onesti, I Zizzari, B Cerbelli, P Sciattella, M Occhipinti, ... Oncotarget 8 (59), 99336, 2017 | 92 | 2017 |
| Immune-related adverse events and survival in solid tumors treated with immune checkpoint inhibitors: a systematic review and meta-analysis F Petrelli, G Grizzi, M Ghidini, A Ghidini, M Ratti, S Panni, M Cabiddu, ... Journal of Immunotherapy 43 (1), 1-7, 2020 | 90 | 2020 |
| Outcomes following immune checkpoint inhibitor treatment of patients with microsatellite instability-high cancers: a systematic review and meta-analysis F Petrelli, M Ghidini, A Ghidini, G Tomasello JAMA oncology 6 (7), 1068-1071, 2020 | 84 | 2020 |
| Clinical and pathological characterization of HER2 mutations in human breast cancer: a systematic review of the literature F Petrelli, G Tomasello, S Barni, V Lonati, R Passalacqua, M Ghidini Breast cancer research and treatment 166, 339-349, 2017 | 81 | 2017 |
| Prognostic role of primary tumor location in non-metastatic gastric cancer: a systematic review and meta-analysis of 50 studies F Petrelli, M Ghidini, S Barni, F Steccanella, G Sgroi, R Passalacqua, ... Annals of surgical oncology 24, 2655-2668, 2017 | 77 | 2017 |
| Use of antibiotics and risk of cancer: a systematic review and meta-analysis of observational studies F Petrelli, M Ghidini, A Ghidini, G Perego, M Cabiddu, S Khakoo, ... Cancers 11 (8), 1174, 2019 | 76 | 2019 |
| A randomized phase II trial of two different 4-drug combinations in advanced pancreatic adenocarcinoma: cisplatin, capecitabine, gemcitabine plus either epirubicin or docetaxel … M Reni, S Cereda, A Rognone, C Belli, M Ghidini, S Longoni, C Fugazza, ... Cancer chemotherapy and pharmacology 69, 115-123, 2012 | 68 | 2012 |
| Timing of adjuvant chemotherapy and survival in colorectal, gastric, and pancreatic cancer. A systematic review and meta-analysis F Petrelli, A Zaniboni, A Ghidini, M Ghidini, L Turati, C Pizzo, M Ratti, ... Cancers 11 (4), 550, 2019 | 63 | 2019 |
| Microsatellite instability and survival in stage II colorectal cancer: a systematic review and meta-analysis F Petrelli, M Ghidini, M Cabiddu, E Pezzica, D Corti, L Turati, A Costanzo, ... Anticancer Research 39 (12), 6431-6441, 2019 | 62 | 2019 |
